Brigade Enterprises Acquires 6.54 Acres of Land In Chennai From Pfizer Healthcare For ₹138.83 Cr

Brigade Enterprises Acquires 6.54 Acres of Land In Chennai From Pfizer Healthcare For ₹138.83 Cr

Through the filing, the company informed that it will be will be developing a residential project on this land parcel with an overall development of over one million square foot.

FPJ Web DeskUpdated: Tuesday, August 22, 2023, 11:32 AM IST
article-image
Brigade Enterprises Acquires 6.54 Acres of Land In Chennai From Pfizer Healthcare For ₹138.83 Cr | Wikipedia

Brigade Enterprises on Tuesday announced that it has acquired 6.54 acres of land parcel located at Rajiv Gandhi Salai (Old Mahabalipuram Road), Sholinganallur, Chennai from Pfizer Healthcare India Private Limited for an overall consideration of Rs 138,83,33,346, the company announced through an exchange filing.

Through the filing, the company informed that it will be will be developing a residential project on this land parcel with an overall development of over one million square foot.

Brigade Enterprises Ltd shares

The shares of Brigade Enterprises on Tuesday at 11:25 am IST were at Rs 588.30, down by 0.63 percent.

RECENT STORIES

Budget 2026 Tax Debate Heats Up, Experts Warn Against Higher Surcharge & Wealth Tax

Budget 2026 Tax Debate Heats Up, Experts Warn Against Higher Surcharge & Wealth Tax

Ladki Bahin Yojana Money Still Not Credited, Here’s What Is The Reason Behind The Delay

Ladki Bahin Yojana Money Still Not Credited, Here’s What Is The Reason Behind The Delay

Income Tax Refunds Still Stuck For Many, Here Is Why Notices Are Coming & What You Should Do?

Income Tax Refunds Still Stuck For Many, Here Is Why Notices Are Coming & What You Should Do?

Malpani Group's Heir Chose Love Over Generational Wealth: Says, 'These Kind Of Decisions Shape...

Malpani Group's Heir Chose Love Over Generational Wealth: Says, 'These Kind Of Decisions Shape...

Sensex & Nifty Face A Nervous Week Ahead, Q3 Results & Global Worries To Set Market Mood

Sensex & Nifty Face A Nervous Week Ahead, Q3 Results & Global Worries To Set Market Mood